Chris Pak

Company: Molecular Targeting Technologies

Job title: Chief Executive Officer & President

Seminars:

EvaThera: A Safe and Effective Targeted-Radiopharmaceutical Platform 4:30 pm

The EvaThera Platform: Extends blood half-life of novel targeting radiopharmaceutical enhances target uptake with low toxicity in non-target organ Improves therapeutic and diagnostic outcomes in SSTR2 and integrinRead more

day: Day One